This week’s Bulls N’ Bears Runner of the Week is … Hydration Pharmaceuticals. The company sold its non-US assets for a sum five times its market capitalisation.
Danish drugmaker Novo Nordisk has eclipsed French luxury group LVMH to become Europe’s most valuable company – thanks to demand for diabetes and weight-loss drugs.
Biomedical engineer Daniel Timms lost his father to heart disease,but their kitchen-top tests helped him hone a radical idea.
The Aus-designed artificial heart set to revolutionise medicine| Preppers go mainstream| A sperm donor’s message to his progeny
Australian researchers are responsible for a series of globally significant medical inventions and innovations.
The future of a government funding program which has assisted teams developing artificial hearts and turning spider venom into drug therapies is in doubt.
Australia will spend $50 million building the world’s first long-term artificial heart,after the original prototype was built with pieces bought from Bunnings.
Investors have punished the company’s share price for the second day in a row – despite it booking revenue of $12.3 billion for the half-year to December 31.
Shares in the blood plasma treatments maker were trading nearly 5 per cent lower following the results.
Australia’s underinvestment in research is becoming a national security issue,some university heads argue,ahead of a landmark review and the AUKUS deal.
After rubbing shoulders in Singapore with Prince William,Sea Forest founder Sam Elsom is eager for the Albanese government to back his plan to help save the planet.